AU5548694A - Peptide inhibitors of tyrosine kinases and therapeutic uses thereof - Google Patents

Peptide inhibitors of tyrosine kinases and therapeutic uses thereof

Info

Publication number
AU5548694A
AU5548694A AU55486/94A AU5548694A AU5548694A AU 5548694 A AU5548694 A AU 5548694A AU 55486/94 A AU55486/94 A AU 55486/94A AU 5548694 A AU5548694 A AU 5548694A AU 5548694 A AU5548694 A AU 5548694A
Authority
AU
Australia
Prior art keywords
tyrosine kinases
therapeutic uses
peptide inhibitors
peptide
inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU55486/94A
Inventor
Ellen Myra Dobrusin
David W. Fry
Dennis Joseph Mcnamara
Juswinder Singh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Lambert Co LLC
Original Assignee
Warner Lambert Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co LLC filed Critical Warner Lambert Co LLC
Publication of AU5548694A publication Critical patent/AU5548694A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU55486/94A 1992-11-06 1993-11-03 Peptide inhibitors of tyrosine kinases and therapeutic uses thereof Abandoned AU5548694A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US139913 1980-04-14
US97313692A 1992-11-06 1992-11-06
US973136 1992-11-06
US13991393A 1993-10-27 1993-10-27
PCT/US1993/010610 WO1994011392A1 (en) 1992-11-06 1993-11-03 Peptide inhibitors of tyrosine kinases and therapeutic uses thereof

Publications (1)

Publication Number Publication Date
AU5548694A true AU5548694A (en) 1994-06-08

Family

ID=26837664

Family Applications (1)

Application Number Title Priority Date Filing Date
AU55486/94A Abandoned AU5548694A (en) 1992-11-06 1993-11-03 Peptide inhibitors of tyrosine kinases and therapeutic uses thereof

Country Status (3)

Country Link
AU (1) AU5548694A (en)
MX (1) MX9306930A (en)
WO (1) WO1994011392A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6066463A (en) * 1993-09-28 2000-05-23 New York University Method and compositions for treatment of BCR-ABL associated leukemias and other cell proliferative disorders
US6107457A (en) * 1995-02-16 2000-08-22 Board Of Regents, The University Of Texas System Bcr-Abl directed compositions and uses for inhibiting Philadelphia chromosome stimulated cell growth
US6133419A (en) * 1996-11-01 2000-10-17 Onyx Pharmaceuticals, Inc. Nucleotide sequences that encode phosphatidylinositol-3' kinase associated proteins and uses thereof
FR2844452A1 (en) * 2002-09-18 2004-03-19 Inst Gustave Roussy Igr Modulating dendritic cell activity, e.g. for treatment of viral infections, NK-sensitive tumors or autoimmune diseases, using inhibitors or specific tyrosine kinases, e.g. c-abl, bcr/abl and c-kit
EP4426715A1 (en) * 2021-11-02 2024-09-11 Enumita AS Tri-, tetra and pentapeptides, compositions thereof and their use in the therapy of psoriasis

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0491675A1 (en) * 1984-01-30 1992-06-24 Imperial Cancer Research Technology Limited Improvements relating to growth factors

Also Published As

Publication number Publication date
WO1994011392A1 (en) 1994-05-26
MX9306930A (en) 1994-08-31

Similar Documents

Publication Publication Date Title
AU5136093A (en) Peptide antagonists of sh2 binding and therapeutic uses thereof
AU673703B2 (en) Injector and use of the same
GB9227026D0 (en) Dual inhibitors of no synthase and cycloosygenase
AU6897094A (en) Identification and use of protease inhibitors
AU3482493A (en) Novel protein tyrosine kinases
AU8760798A (en) Irreversible inhibitors of tyrosine kinases
PL322584A1 (en) Inhibitors of proteinous kinase c
PL326754A1 (en) Inhibitors of proteinous kinase c
AU8665998A (en) Irreversible bicyclic inhibitors of tyrosine kinases
AU3000297A (en) Use of protein kinase c inhibitors to enhance the clinical efficacy of oncolytic agents and radiation therapy
AU4267293A (en) Use of MMP inhibitors
HU9303218D0 (en) Application of atp-depended protease and its inhibitor for treatment of cachexy and amyotrophia
AU4230196A (en) Treatment of pancreatic tumors with peptide yy and analogs thereof
IL122427A0 (en) Pharmaceutical compositions and methods for inhibition of adaptor protein/tyrosine kinase interactions
HUT71324A (en) Peptide inhibitors of mitogenesis and motogenesis
AU3993795A (en) Peptide compounds for prevention and/or treatment of no-mediated diseases
EP0863762A4 (en) Methods of production and use of liquid formulations of plasma proteins
AU4840293A (en) Cloning and expression of pur protein
AU6359594A (en) Pharmaceutical tryptophan containing dipeptide compositions and methods of use thereof
AU1616499A (en) Chemokine variants and methods of use
AU1436797A (en) Mitogen-activated protein kinase kinase mek6 and methods of use therefor
AU4362696A (en) Growth inhibitory peptide and methods of using same
AU6098194A (en) Analogs of receptor tyrosine activation motifs and therapeutic uses thereof
AU4382693A (en) Therapeutic uses of pungent botanicals and their related compounds
AU5548694A (en) Peptide inhibitors of tyrosine kinases and therapeutic uses thereof